APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 5

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global C-C Chemokine Receptor Type 5 Industry Growth and Trends Forecast to 2032

26 December 202593 pages

Choose your research edition.

Industry ResearchC-C Chemokine Receptor Type 5 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal C-C Chemokine Receptor Type 5 Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal C-C Chemokine Receptor Type 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-C Chemokine Receptor Type 5 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C-C Chemokine Receptor Type 5 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C-C Chemokine Receptor Type 5 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C-C Chemokine Receptor Type 5 include Allergan Plc, American Gene Technologies International Inc, Bristol-Myers Squibb Company, ChemoCentryx Inc, Cytodyn Inc, Pharis Biotec GmbH, GlaxoSmithKline Plc and TaiwanJ Pharmaceuticals Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global C-C Chemokine Receptor Type 5 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The C-C Chemokine Receptor Type 5 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C-C Chemokine Receptor Type 5 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C-C Chemokine Receptor Type 5.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global C-C Chemokine Receptor Type 5 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

C-C Chemokine Receptor Type 5 Market by Company

Allergan Plc

American Gene Technologies International Inc

Bristol-Myers Squibb Company

ChemoCentryx Inc

Cytodyn Inc

Pharis Biotec GmbH

GlaxoSmithKline Plc

TaiwanJ Pharmaceuticals Co Ltd

C-C Chemokine Receptor Type 5 Segment by Type

DS-001

CCL-14

BMS-813160

AG-1105

Others

C-C Chemokine Receptor Type 5 Segment by Application

Infectious Disease

Immunology

Gastrointestinal

Oncology

Others

C-C Chemokine Receptor Type 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 5 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of C-C Chemokine Receptor Type 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DS-001 Table 2. Major Company of CCL-14 Table 3. Major Company of BMS-813160 Table 4. Major Company of AG-1105 Table 5. Major Company of Others Table 6. Global C-C Chemokine Receptor Type 5 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 8. Global C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type (2021-2026) Table 9. Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (US$ Million) Table 10. Global C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type (2021-2026) Table 11. Global C-C Chemokine Receptor Type 5 Price by Type (2021-2026) & (US$/Unit) Table 12. Global C-C Chemokine Receptor Type 5 Sales by Type (2027-2032) & (W Units) Table 13. Global C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type (2027-2032) Table 14. Global C-C Chemokine Receptor Type 5 Sales by Type (2027-2032) & (US$ Million) Table 15. Global C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type (2027-2032) Table 16. Global C-C Chemokine Receptor Type 5 Price by Type (2027-2032) & (US$/Unit) Table 17. North America C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 18. North America C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 20. Europe C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 24. Latin America C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (US$ Million) Table 27. C-C Chemokine Receptor Type 5 Industry Trends Table 28. C-C Chemokine Receptor Type 5 Industry Drivers Table 29. C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges Table 30. C-C Chemokine Receptor Type 5 Industry Restraints Table 31. Global C-C Chemokine Receptor Type 5 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Company (2021-2026) Table 33. Global C-C Chemokine Receptor Type 5 Sales by Company (2021-2026) & (W Units) Table 34. Global C-C Chemokine Receptor Type 5 Sales Share by Company (2021-2026) Table 35. Global C-C Chemokine Receptor Type 5 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global C-C Chemokine Receptor Type 5 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global C-C Chemokine Receptor Type 5 Major Company Production Sites and Headquarters Table 38. Global C-C Chemokine Receptor Type 5 Company, Product Type & Application Table 39. Global C-C Chemokine Receptor Type 5 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global C-C Chemokine Receptor Type 5 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global C-C Chemokine Receptor Type 5 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2026) & (W Units) Table 44. Global C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Region (2021-2026) Table 45. Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2026) & (US$ Million) Table 46. Global C-C Chemokine Receptor Type 5 Sales Market Share in Value by Region (2021-2026) Table 47. Global C-C Chemokine Receptor Type 5 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global C-C Chemokine Receptor Type 5 Sales by Region (2027-2032) & (W Units) Table 49. Global C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Region (2027-2032) Table 50. Global C-C Chemokine Receptor Type 5 Sales by Region (2027-2032) & (US$ Million) Table 51. Global C-C Chemokine Receptor Type 5 Sales Market Share in Value by Region (2027-2032) Table 52. Global C-C Chemokine Receptor Type 5 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global C-C Chemokine Receptor Type 5 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 55. Global C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application (2021-2026) Table 56. Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (US$ Million) Table 57. Global C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application (2021-2026) Table 58. Global C-C Chemokine Receptor Type 5 Price by Application (2021-2026) & (US$/Unit) Table 59. Global C-C Chemokine Receptor Type 5 Sales by Application (2027-2032) & (W Units) Table 60. Global C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application (2027-2032) Table 61. Global C-C Chemokine Receptor Type 5 Sales by Application (2027-2032) & (US$ Million) Table 62. Global C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application (2027-2032) Table 63. Global C-C Chemokine Receptor Type 5 Price by Application (2027-2032) & (US$/Unit) Table 64. North America C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 65. North America C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 67. Europe C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 71. Latin America C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (US$ Million) Table 74. Allergan Plc Company Information Table 75. Allergan Plc Business Overview Table 76. Allergan Plc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio Table 78. Allergan Plc Recent Development Table 79. American Gene Technologies International Inc Company Information Table 80. American Gene Technologies International Inc Business Overview Table 81. American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 83. American Gene Technologies International Inc Recent Development Table 84. Bristol-Myers Squibb Company Company Information Table 85. Bristol-Myers Squibb Company Business Overview Table 86. Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio Table 88. Bristol-Myers Squibb Company Recent Development Table 89. ChemoCentryx Inc Company Information Table 90. ChemoCentryx Inc Business Overview Table 91. ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 93. ChemoCentryx Inc Recent Development Table 94. Cytodyn Inc Company Information Table 95. Cytodyn Inc Business Overview Table 96. Cytodyn Inc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 98. Cytodyn Inc Recent Development Table 99. Pharis Biotec GmbH Company Information Table 100. Pharis Biotec GmbH Business Overview Table 101. Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio Table 103. Pharis Biotec GmbH Recent Development Table 104. GlaxoSmithKline Plc Company Information Table 105. GlaxoSmithKline Plc Business Overview Table 106. GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio Table 108. GlaxoSmithKline Plc Recent Development Table 109. TaiwanJ Pharmaceuticals Co Ltd Company Information Table 110. TaiwanJ Pharmaceuticals Co Ltd Business Overview Table 111. TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio Table 113. TaiwanJ Pharmaceuticals Co Ltd Recent Development Table 114. North America C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 115. North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 116. North America C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2026) Table 117. North America C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032) & (W Units) Table 118. North America C-C Chemokine Receptor Type 5 Sales Market Share Forecast by Country (2027-2032) Table 119. North America C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026) & (US$ Million) Table 121. North America C-C Chemokine Receptor Type 5 Market Share by Country (2021-2026) Table 122. North America C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America C-C Chemokine Receptor Type 5 Market Share Forecast by Country (2027-2032) Table 124. Europe C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 125. Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 126. Europe C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2026) Table 127. Europe C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032) & (W Units) Table 128. Europe C-C Chemokine Receptor Type 5 Sales Market Share Forecast by Country (2027-2032) Table 129. Europe C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe C-C Chemokine Receptor Type 5 Market Share by Country (2021-2026) Table 132. Europe C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe C-C Chemokine Receptor Type 5 Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 136. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032) & (W Units) Table 138. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific C-C Chemokine Receptor Type 5 Market Share by Country (2021-2026) Table 142. Asia-Pacific C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific C-C Chemokine Receptor Type 5 Market Share Forecast by Country (2027-2032) Table 144. Latin America C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Latin America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 146. Latin America C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2026) Table 147. Latin America C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032) & (W Units) Table 148. Latin America C-C Chemokine Receptor Type 5 Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America C-C Chemokine Receptor Type 5 Market Share by Country (2021-2026) Table 152. Latin America C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America C-C Chemokine Receptor Type 5 Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 156. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032) & (W Units) Table 158. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa C-C Chemokine Receptor Type 5 Market Share by Country (2021-2026) Table 162. Middle East and Africa C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa C-C Chemokine Receptor Type 5 Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. C-C Chemokine Receptor Type 5 Distributors List Table 167. C-C Chemokine Receptor Type 5 Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. C-C Chemokine Receptor Type 5 Image Figure 2. Global C-C Chemokine Receptor Type 5 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C-C Chemokine Receptor Type 5 Market Size (2021-2032) & (US$ Million) Figure 4. Global C-C Chemokine Receptor Type 5 Sales (2021-2032) & (W Units) Figure 5. DS-001 Image Figure 6. Global DS-001 Sales YoY Growth (2021-2032) & (W Units) Figure 7. CCL-14 Image Figure 8. Global CCL-14 Sales YoY Growth (2021-2032) & (W Units) Figure 9. BMS-813160 Image Figure 10. Global BMS-813160 Sales YoY Growth (2021-2032) & (W Units) Figure 11. AG-1105 Image Figure 12. Global AG-1105 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global C-C Chemokine Receptor Type 5 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global C-C Chemokine Receptor Type 5 Market Share by Type 2025 VS 2032 Figure 17. North America C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type in 2025 Figure 18. North America C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type in 2025 Figure 19. Europe C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type in 2025 Figure 20. Europe C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type in 2025 Figure 23. Latin America C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 C-C Chemokine Receptor Type 5 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Infectious Disease Image Figure 30. Global Infectious Disease Sales YoY Growth (2021-2032) & (W Units) Figure 31. Immunology Image Figure 32. Global Immunology Sales YoY Growth (2021-2032) & (W Units) Figure 33. Gastrointestinal Image Figure 34. Global Gastrointestinal Sales YoY Growth (2021-2032) & (W Units) Figure 35. Oncology Image Figure 36. Global Oncology Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global C-C Chemokine Receptor Type 5 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global C-C Chemokine Receptor Type 5 Market Share by Application 2025 VS 2032 Figure 41. North America C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application in 2025 Figure 42. North America C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application in 2025 Figure 43. Europe C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application in 2025 Figure 44. Europe C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application in 2025 Figure 47. Latin America C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application in 2025 Figure 48. Latin America C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share in Value by Application in 2025 Figure 51. North America C-C Chemokine Receptor Type 5 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America C-C Chemokine Receptor Type 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America C-C Chemokine Receptor Type 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe C-C Chemokine Receptor Type 5 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe C-C Chemokine Receptor Type 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe C-C Chemokine Receptor Type 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific C-C Chemokine Receptor Type 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific C-C Chemokine Receptor Type 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America C-C Chemokine Receptor Type 5 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America C-C Chemokine Receptor Type 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America C-C Chemokine Receptor Type 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa C-C Chemokine Receptor Type 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. C-C Chemokine Receptor Type 5 Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. C-C Chemokine Receptor Type 5 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • DS-001
  • CCL-14
  • BMS-813160
  • AG-1105
  • Others
Applications
  • Infectious Disease
  • Immunology
  • Gastrointestinal
  • Oncology
  • Others
Companies covered
  • Allergan Plc
  • American Gene Technologies International Inc
  • Bristol-Myers Squibb Company
  • ChemoCentryx Inc
  • Cytodyn Inc
  • Pharis Biotec GmbH
  • GlaxoSmithKline Plc
  • TaiwanJ Pharmaceuticals Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C-C Chemokine Receptor Type 5 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global C-C Chemokine Receptor Type 5 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 C-C Chemokine Receptor Type 5 Market by Type
  6. 1.3.1 DS-001
  7. 1.3.2 CCL-14
  8. 1.3.3 BMS-813160
  9. 1.3.4 AG-1105
  10. 1.3.5 Others
  11. 1.4 Global C-C Chemokine Receptor Type 5 Market Size by Type
  12. 1.4.1 Global C-C Chemokine Receptor Type 5 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global C-C Chemokine Receptor Type 5 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global C-C Chemokine Receptor Type 5 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America C-C Chemokine Receptor Type 5 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe C-C Chemokine Receptor Type 5 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific C-C Chemokine Receptor Type 5 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America C-C Chemokine Receptor Type 5 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa C-C Chemokine Receptor Type 5 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 C-C Chemokine Receptor Type 5 Industry Trends
  2. 2.2 C-C Chemokine Receptor Type 5 Industry Drivers
  3. 2.3 C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges
  4. 2.4 C-C Chemokine Receptor Type 5 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by C-C Chemokine Receptor Type 5 Revenue (2021-2026)
  2. 3.2 Global Top Players by C-C Chemokine Receptor Type 5 Sales (2021-2026)
  3. 3.3 Global Top Players by C-C Chemokine Receptor Type 5 Price (2021-2026)
  4. 3.4 Global C-C Chemokine Receptor Type 5 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C-C Chemokine Receptor Type 5 Major Company Production Sites & Headquarters
  6. 3.6 Global C-C Chemokine Receptor Type 5 Company, Product Type & Application
  7. 3.7 Global C-C Chemokine Receptor Type 5 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C-C Chemokine Receptor Type 5 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C-C Chemokine Receptor Type 5 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C-C Chemokine Receptor Type 5 Tier 1, Tier 2, and Tier 3
4 C-C Chemokine Receptor Type 5 Regional Status and Outlook
  1. 4.1 Global C-C Chemokine Receptor Type 5 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global C-C Chemokine Receptor Type 5 Historic Market Size by Region
  3. 4.2.1 Global C-C Chemokine Receptor Type 5 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global C-C Chemokine Receptor Type 5 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global C-C Chemokine Receptor Type 5 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global C-C Chemokine Receptor Type 5 Forecasted Market Size by Region
  7. 4.3.1 Global C-C Chemokine Receptor Type 5 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global C-C Chemokine Receptor Type 5 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global C-C Chemokine Receptor Type 5 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 C-C Chemokine Receptor Type 5 by Application
  1. 5.1 C-C Chemokine Receptor Type 5 Market by Application
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Immunology
  4. 5.1.3 Gastrointestinal
  5. 5.1.4 Oncology
  6. 5.1.5 Others
  7. 5.2 Global C-C Chemokine Receptor Type 5 Market Size by Application
  8. 5.2.1 Global C-C Chemokine Receptor Type 5 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global C-C Chemokine Receptor Type 5 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global C-C Chemokine Receptor Type 5 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America C-C Chemokine Receptor Type 5 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe C-C Chemokine Receptor Type 5 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific C-C Chemokine Receptor Type 5 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America C-C Chemokine Receptor Type 5 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa C-C Chemokine Receptor Type 5 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan Plc
  2. 6.1.1 Allergan Plc Company Information
  3. 6.1.2 Allergan Plc Business Overview
  4. 6.1.3 Allergan Plc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio
  6. 6.1.5 Allergan Plc Recent Developments
  7. 6.2 American Gene Technologies International Inc
  8. 6.2.1 American Gene Technologies International Inc Company Information
  9. 6.2.2 American Gene Technologies International Inc Business Overview
  10. 6.2.3 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio
  12. 6.2.5 American Gene Technologies International Inc Recent Developments
  13. 6.3 Bristol-Myers Squibb Company
  14. 6.3.1 Bristol-Myers Squibb Company Company Information
  15. 6.3.2 Bristol-Myers Squibb Company Business Overview
  16. 6.3.3 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 6.4 ChemoCentryx Inc
  20. 6.4.1 ChemoCentryx Inc Company Information
  21. 6.4.2 ChemoCentryx Inc Business Overview
  22. 6.4.3 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio
  24. 6.4.5 ChemoCentryx Inc Recent Developments
  25. 6.5 Cytodyn Inc
  26. 6.5.1 Cytodyn Inc Company Information
  27. 6.5.2 Cytodyn Inc Business Overview
  28. 6.5.3 Cytodyn Inc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio
  30. 6.5.5 Cytodyn Inc Recent Developments
  31. 6.6 Pharis Biotec GmbH
  32. 6.6.1 Pharis Biotec GmbH Company Information
  33. 6.6.2 Pharis Biotec GmbH Business Overview
  34. 6.6.3 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio
  36. 6.6.5 Pharis Biotec GmbH Recent Developments
  37. 6.7 GlaxoSmithKline Plc
  38. 6.7.1 GlaxoSmithKline Plc Company Information
  39. 6.7.2 GlaxoSmithKline Plc Business Overview
  40. 6.7.3 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio
  42. 6.7.5 GlaxoSmithKline Plc Recent Developments
  43. 6.8 TaiwanJ Pharmaceuticals Co Ltd
  44. 6.8.1 TaiwanJ Pharmaceuticals Co Ltd Company Information
  45. 6.8.2 TaiwanJ Pharmaceuticals Co Ltd Business Overview
  46. 6.8.3 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio
  48. 6.8.5 TaiwanJ Pharmaceuticals Co Ltd Recent Developments
7 North America by Country
  1. 7.1 North America C-C Chemokine Receptor Type 5 Sales by Country
  2. 7.1.1 North America C-C Chemokine Receptor Type 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026)
  4. 7.1.3 North America C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032)
  5. 7.2 North America C-C Chemokine Receptor Type 5 Market Size by Country
  6. 7.2.1 North America C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026)
  8. 7.2.3 North America C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe C-C Chemokine Receptor Type 5 Sales by Country
  2. 8.1.1 Europe C-C Chemokine Receptor Type 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2026)
  4. 8.1.3 Europe C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe C-C Chemokine Receptor Type 5 Market Size by Country
  6. 8.2.1 Europe C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026)
  8. 8.2.3 Europe C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Country
  2. 9.1.1 Asia-Pacific C-C Chemokine Receptor Type 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific C-C Chemokine Receptor Type 5 Market Size by Country
  6. 9.2.1 Asia-Pacific C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America C-C Chemokine Receptor Type 5 Sales by Country
  2. 10.1.1 South America C-C Chemokine Receptor Type 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026)
  4. 10.1.3 South America C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032)
  5. 10.2 South America C-C Chemokine Receptor Type 5 Market Size by Country
  6. 10.2.1 South America C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026)
  8. 10.2.3 South America C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country
  2. 11.1.1 Middle East and Africa C-C Chemokine Receptor Type 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa C-C Chemokine Receptor Type 5 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa C-C Chemokine Receptor Type 5 Market Size by Country
  6. 11.2.1 Middle East and Africa C-C Chemokine Receptor Type 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa C-C Chemokine Receptor Type 5 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa C-C Chemokine Receptor Type 5 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 C-C Chemokine Receptor Type 5 Value Chain Analysis
  2. 12.1.1 C-C Chemokine Receptor Type 5 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 C-C Chemokine Receptor Type 5 Production Mode & Process
  7. 12.2 C-C Chemokine Receptor Type 5 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 C-C Chemokine Receptor Type 5 Distributors
  10. 12.2.3 C-C Chemokine Receptor Type 5 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst